-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $55

Benzinga·03/06/2025 15:15:35
Listen to the news
Citigroup analyst Yigal Nochomovitz maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and raises the price target from $49 to $55.